Radiomics in Clinical Trials – The Rationale, Current Practices, and Future Considerations

Read the publication >

Radiomics involves deep quantitative analysis of radiological images for structural and/or functional information. – It is a phenomic assessment of disease to understand lesion microstructure, microenvironment and molecular/cellular function. – In oncology, it helps us accurately classify, stratify and prognosticate tumors based on if, how and when they transform, infiltrate, involute or metastasize, – Utilizing radiomics in clinical trials is exploratory, and not an established end-point. – Integrating radiomics in an imaging-based clinical trials involves a streamlined workflow to handle large datasets, robust platforms to accommodate machine learning calculations, and seamless incorporation of derived insights into outcomes matrix.

Contact Us

Phone Icon

T: +44 7413 022053

Email Icon

E: contact@ia-grp.com

Address Icon

QABC Minster House,
272-274 Vauxhall Bridge Road, London, SW1V 1BA
United Kingdom